Subramanian Yegneswaran

Subramanian Yegneswaran has extensive work experience in the field of medical research and development. Subramanian currently serves as the Director of Transfusion Medicine Research at Cerus, a position they assumed in January 2022. Prior to this role, they held the position of Director of Platelet, Plasma Therapeutics at Cerus from March 2020 to December 2021. From April 2017 to March 2020, Subramanian was the Director of Development at Cerus.

Before joining Cerus, Subramanian worked at Bayer starting in August 2011. Subramanian served as the Project Leader for Global Drug Discovery, Hematology Research. In this role, they were responsible for leading multiple projects related to Hemoglobinopathies and Hemophilia. Subramanian effectively managed and coordinated with global cross-functional teams, ensuring timely delivery of project data. Subramanian also provided subject matter expertise and co-supervised two postdoctoral researchers from the University of California San Francisco.

Prior to Bayer, Subramanian worked as a Staff Scientist in the Molecular and Experimental Medicine department at The Scripps Research Institute from August 2007 to August 2011. Subramanian also held the position of Senior Research Associate in the same department from an unspecified date in 2003 to 2007.

Overall, Subramanian Yegneswaran has a diverse work experience that includes leadership roles in research and development, as well as expertise in transfusion medicine and molecular medicine.

Subramanian Yegneswaran has a Post-doctorate degree in Molecular and Experimental Medicine from Scripps Research. Prior to that, they obtained a PhD in Medical Sciences, specializing in the Department of Medical Biochemistry and Genetics, from Texas A&M University, specifically from the TAMU Health Sciences Center. Yegneswaran's educational journey began at the University of Oklahoma, where they studied Chemistry & Biochemistry.